Fibrogen

Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology.

placeSan Francisco, California, United States calendar_todayFounded 1993 groups592 employees language fibrogen.com

Registered entities

Innovation

99 patent families (59 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing, Emerging technologies; filing pace slowing. Cited 12,502 times.

YearFilings
201527
201616
201718
201811
201914
202012
202111
202210
20238
202411
20256
20261

Investor mix

28 investors on record; lead investors include Adage Capital Management; 1 has since exited.

Investor typeCountShare
Venture capital1036%
Private equity725%
Angel & family office14%
Bank & private debt14%
Other / undisclosed932%
Coming soon